Healthcare News and Research

Latest Healthcare News and Research

Studies expose high prevalence of epilepsy and other neurological disorders in US Veterans

Three studies coming out of the American Epilepsy Society's 67th Annual Meeting in Washington DC expose the high prevalence of epilepsy and other neurological disorders in US Veterans who served in Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn. The research conducted from these studies indicate that veterans are at a particularly high risk for traumatic brain injury, post traumatic stress disorder, psychological non-epileptic seizures and epileptic seizure diagnoses.

10 Dec 2013

Viewpoints: Optimism about Obamacare; 834 errors; can-you-keep-your-doctor debate

This was the week when liberals decided that it was safe to feel optimistic about Obamacare again. ... A worst-case scenario, in which the website remained unusable well into the new year, seems to have been averted, and with it the danger that insurers or Congressional Democrats would begin to bail on Obamacare entirely.

10 Dec 2013

Scientists devise method to measure forces in 3D tissues, living embryos

As embryonic tissue develops, cells push and pull on each other, and they must do so correctly for the tissue to develop properly. Now scientists at Harvard University have devised the first method to measure these forces in three-dimensional (3D) tissues and living embryos.

10 Dec 2013

New federal exchange glitch: Sending unqualified people to Medicaid; meanwhile, Penn. plans Medicaid expansion

USA Today reports that the National Association of State Medicaid Directors may release more information this week about how the federal exchange may be mislabelling people as Medicaid-qualified.

10 Dec 2013

Implementation issues: Optimism, winners, losers and what about those paper applications?

News outlets examine a range of health law issues, including a look at some of the consumers who approach the overhaul with a sense of relief and optimism. Meanwhile, while insurance agents are feeling left out, public relations firms see the law as a boon.

10 Dec 2013

ImmunoGen presents Phase I trial results of SAR650984 at ASH annual meeting

ImmunoGen, Inc., a biotechnology company that develops targeted, antibody-based anticancer therapeutics, today announced the first clinical findings with SAR650984 reported in an oral presentation at the ASH annual meeting. The data are from an ongoing Phase I trial assessing this CD38-targeting therapeutic antibody in patients with CD38-positive MM or other hematologic malignancy.

10 Dec 2013

Study demonstrates feasibility to detect generalized tonic-clonic seizures with arm device

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures, or convulsions, during activities of daily living. Two new studies presented at the American Epilepsy Society's 67th Annual Meeting in Washington D.C. provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.

10 Dec 2013

New findings on effects of epilepsy on mother and child

New research pertaining to the latest findings on the effects of epilepsy on both the mother and child were presented at the American Epilepsy Society's 67th Annual Meeting in Washington DC. These studies explore folic acid use, the effect of surgery with intractable focal epilepsy, and antiepileptic drug exposure during breastfeeding.

10 Dec 2013

Deductibles, other health plan costs may surprise consumers

News outlets report that, as more details become available, some people may find that their health insurance in 2014 will cost more than they hoped.

10 Dec 2013

Former Obama Aide Phil Schiliro returns to help oversee Obamacare

Schiliro is the president's former congressional liaison.

10 Dec 2013

IBN and IBM discover new medical application for converted PET bottles

Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research - Almaden (IBM) have discovered a new, potentially life-saving application for polyethylene terephthalate (PET), which is widely used to make plastic bottles.

10 Dec 2013

Maryland's online insurance marketplace plagued by technical issues, discord

The director of the state exchange resigned Friday. Meanwhile, the web portal continues to be marked by operational difficulties that are undermining enrollment efforts.

9 Dec 2013

New material effective in destroying drug-resistant fungi

Researchers at Singapore’s Institute of Bioengineering and Nanotechnology (IBN) and California’s IBM Research – Almaden (IBM) have discovered a new, potentially life-saving application for polyethylene terephthalate (PET), which is widely used to make plastic bottles.

9 Dec 2013

Adocia gets development and commercialization rights in nanotechnology for drug delivery

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today the signature of an exclusive license agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science Transfert.

9 Dec 2013

First Edition: December 9, 2013

Today's headlines include reports about new sticker-shock concerns over costs for coverage purchased through the health law's new online insurance marketplaces.

9 Dec 2013

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan Africa.

9 Dec 2013

Children and adults with high-risk ALL benefit from novel, personalized cell therapy

Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient's immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children's Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.

9 Dec 2013

Children with epilepsy at higher risk for mood and behavior disorders

Children with epilepsy are at high risk for depression, anxiety, and behavioral functioning disorders. Mood and behavior are known to change or improve in children following epilepsy surgery, but research is inconsistent concerning the extent of the change.

9 Dec 2013

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients

Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.

9 Dec 2013

Revised Clinical Practice Guidelines on management of HCV published by EASL

The European Association for the Study of the Liver today publishes their revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection. The EASL guidelines, which supersede the previous version published in 2011, are designed to help physicians and other healthcare providers optimise their management of patients with acute and chronic HCV.

9 Dec 2013

Healthcare News and Research

Latest Healthcare News and Research

Studies expose high prevalence of epilepsy and other neurological disorders in US Veterans

Viewpoints: Optimism about Obamacare; 834 errors; can-you-keep-your-doctor debate

Scientists devise method to measure forces in 3D tissues, living embryos

New federal exchange glitch: Sending unqualified people to Medicaid; meanwhile, Penn. plans Medicaid expansion

Implementation issues: Optimism, winners, losers and what about those paper applications?

ImmunoGen presents Phase I trial results of SAR650984 at ASH annual meeting

Study demonstrates feasibility to detect generalized tonic-clonic seizures with arm device

New findings on effects of epilepsy on mother and child

Deductibles, other health plan costs may surprise consumers

Former Obama Aide Phil Schiliro returns to help oversee Obamacare

IBN and IBM discover new medical application for converted PET bottles

Maryland's online insurance marketplace plagued by technical issues, discord

New material effective in destroying drug-resistant fungi

Adocia gets development and commercialization rights in nanotechnology for drug delivery

First Edition: December 9, 2013

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Children and adults with high-risk ALL benefit from novel, personalized cell therapy

Children with epilepsy at higher risk for mood and behavior disorders

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients

Revised Clinical Practice Guidelines on management of HCV published by EASL

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in